Table 1.

Summary of clinical information from TCGA with each entry indicating number of samples.

Gender		AJCC pathologic stage		Treatment		Primary diagnosis subtypes
Lung adenocarcinoma
Male	220	Stage IA	124	Pharmacotherapy only	56	Adenocarcinoma, NOS	311
Female	259	Stage IB	131	Radiotherapy only	101	Adenocarcinoma with mixed subtypes	108
Missing	50	Stage IIA	46	Both therapies	70	Papillary	22
		Stage IIB	63	No treatment	242	Bronchiolo-alveolar, NOS	3
		Stage IIIA	66	Missing	60	Bronchiolo-alveolar, nonmucinous	19
		Stage IIIB	11			Brionchio-alviolar Carcinoma, mucinous	5
		Stage IV	24			Micropapillary	3
		Stage I	5			Clear cell	2
		Stage II	1			Solid carcinoma	6
		Missing	58			Missing	50
Lung squamous cell carcinoma
Male	368	Stage IA	89	Pharmacotherapy only	57	Squamous cell carcinoma, NOS	465
Female	130	Stage IB	150	Radiotherapy only	65	Basaloid	14
		Stage IIA	64	Both therapies	48	Keratinizing	13
		Stage IIB	94	No treatment	265	Papillary	3
		Stage IIIA	63	Missing	63	Large cell, nonkeratinizing	2
		Stage IIIB	18			Small cell, nonkeratinizing	1
		Stage IV	7
		Stage I	3
		Stage II	3
		Stage III	3
		Missing	4